Laura Porter, MD

Co-Investigator, Patient Advocate

Organization: Independent medical advisor and patient advocate
Meet Laura Porter, MD

Laura Porter, MD

Designation:

Co-Investigator, Patient Advocate

Organizations:

Independent medical advisor and patient advocate

Discipline:

Medicine; Advocacy

Dr. Laura Porter is a stage IV colon cancer survivor and has worked as a patient advocate in a variety of roles, including research advocacy, grant reviews, as a Medical Advisor for advocacy organizations, educational support, support groups, one-on-one support, and writing blogs for advocacy organizations.  

As a research advocate, she serves on the NCI Rectal-Anal Task Force, and the Patient Advocate Steering Committee. She serves on several committees with ASCO including the Onco-PCP Task Force, to incorporate primary care and oncologists so the survivors have appropriate follow-up, once treatment ends.  She is on two panels with the National Quality Forum including being on the Opioid Technical Expert Panel.  She reviews grants as a patient advocate for Cancer Prevention and Research Institute of Texas (CPRIT), Conquer Cancer and the Colorectal Cancer Alliance.  She is a Special Government Employee at the FDA. She is currently a Co-Investigator on an international grant through Cancer Research United Kingdom, team OPTIMISITICC. She is responsible for the recruitment and management of the patient advocates on the project.

Dr. Laura Porter is a stage IV colon cancer survivor and has worked as a patient advocate in a variety of roles, including research advocacy, grant reviews, as a Medical Advisor for advocacy organizations, educational support, support groups, one-on-one support, and writing blogs for advocacy organizations.  

As a research advocate, she serves on the NCI Rectal-Anal Task Force, and the Patient Advocate Steering Committee. She serves on several committees with ASCO including the Onco-PCP Task Force, to incorporate primary care and oncologists so the survivors have appropriate follow-up, once treatment ends.  She is on two panels with the National Quality Forum including being on the Opioid Technical Expert Panel.  She reviews grants as a patient advocate for Cancer Prevention and Research Institute of Texas (CPRIT), Conquer Cancer and the Colorectal Cancer Alliance.  She is a Special Government Employee at the FDA. She is currently a Co-Investigator on an international grant through Cancer Research United Kingdom, team OPTIMISITICC. She is responsible for the recruitment and management of the patient advocates on the project.